BRUSSELS, BELGIUM--(MARKET WIRE)--Aug 17, 2007 -- Marketing Authorization Application for Vimpat® - the proposed new trade name for lacosamide - to treat Diabetic Neuropathic Pain has been submitted to the European regulatory authority.
BRUSSELS, BELGIUM--(MARKET WIRE)--Aug 17, 2007 -- Marketing Authorization Application for Vimpat® - the proposed new trade name for lacosamide - to treat Diabetic Neuropathic Pain has been submitted to the European regulatory authority.
